BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17568659)

  • 1. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
    Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
    Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
    Gohil R; Peck G; Sharma P
    Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factor XIII-A subunit Val34Leu polymorphism and risk of venous thromboembolism in young adults].
    Demyanenko AV; Kapustin SI; Soroka VV; Chechulov PV
    Angiol Sosud Khir; 2015; 21(2):21-5. PubMed ID: 26035561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
    Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
    Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study.
    Rasmussen-Torvik LJ; Cushman M; Tsai MY; Zhang Y; Heckbert SR; Rosamond WD; Folsom AR
    Thromb Res; 2007; 121(1):1-7. PubMed ID: 17433418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
    Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
    J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control study.
    Delluc A; Gourhant L; Lacut K; Mercier B; Audrezet MP; Nowak E; Oger E; Leroyer C; Mottier D; Le Gal G; Couturaud F
    Thromb Haemost; 2010 Jun; 103(6):1161-9. PubMed ID: 20352152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
    Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
    Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients.
    Leroyer C; Mercier B; Oger E; Chenu E; Abgrall JF; Férec C; Mottier D
    Thromb Haemost; 1998 Jul; 80(1):49-51. PubMed ID: 9684784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis.
    Zee RY; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Ridker PM
    Circulation; 2006 May; 113(18):2193-200. PubMed ID: 16651467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
    Kobbervig C; Williams E
    Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
    Kattula S; Bagoly Z; Tóth NK; Muszbek L; Wolberg AS
    J Thromb Haemost; 2020 Apr; 18(4):885-894. PubMed ID: 31989767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
    Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
    Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.
    Carter AM; Catto AJ; Kohler HP; Ariëns RA; Stickland MH; Grant PJ
    Blood; 2000 Aug; 96(3):1177-9. PubMed ID: 10910940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.